Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients
Purpose: Scarcity of donor availability has led to increased rates of HCV viremic donors (NAAT+). We aimed to assess the impact of NAAT+ donors on dd-cfDNA and GEP results in Heart Transplantrecipients.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: , A. Fernandez Valledor, D. Oren, A. Rahman, G. Rubinstein, S. Rahman, C. Lee, J. Baranowska, M. Regan, Y. Mehlman, D. Lotan, E.M. DeFilippis, K. Theodoropoulos, J. Fried, V. Topkara, D. Majure, P. Colombo, J. Raikhelkar, M. Yuzefpolskaya, K. Clerkin, F. Source Type: research
More News: Cardiology | Genetics | Heart | Heart Transplant | Hepatitis | Hepatitis C | Lung Transplant | Transplant Surgery | Transplants